Single nucleotide polymorphism array analysis of cancer

Current Opinion in Oncology

Volumn 19, Issue 1, 2007, Pages 43-49

  Dutt, Amit ^a,b   Beroukhim, Rameen ^a,b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer; Copy number variation; Loss of heterozygosity; SNP array

Indexed keywords

DNA;

ALLELE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COPY NUMBER VARIATION; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HETEROZYGOSITY LOSS; HIGH THROUGHPUT SCREENING; HUMAN; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL GENETICS; TUMOR SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; GENOME, HUMAN; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33845350493     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328011a8c1     Document Type: Review

References (45)

1. Bignell GR, Huang J, Greshock J, et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res 2004; 14:287-295.
2. Zhao X, Li C, Paez JG, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004; 64:3060-3071.
3. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33 (Suppl):228-237.
4. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001; 27:234-236.
5. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320.
6. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
7. Nicolas P, Sun F, Li LM. A model-based approach to selection of tag SNPs. BMC Bioinformatics 2006; 7:303.
8. Cutler JA, Mitchell MJ, Greenslade K, et al. A rapid and cost-effective method for analysis of three common genetic risk factors for thrombosis. Blood Coagul Fibrinolysis 2001; 12:33-36.
9. Gunderson KL, Steemers FJ, Lee G, et al. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 2005; 37:549-554. Describes the development of bead-based array for genome-wide SNP genotyping and copy number analysis.
10. Matsuzaki H, Dong S, Loi H, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 2004; 1:109-111.
11. Hardenbol P, Baner J, Jain M, et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat Biotechnol 2003; 21:673-678.
12. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14:1675-1680.
13. Gunderson KL, Kruglyak S, Graige MS, et al. Decoding randomly ordered DNA arrays. Genome Res 2004; 14:870-877.
14. Lieberfarb ME, Lin M, Lechpammer M, et al. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res 2003; 63:4781-4785.
15. Lin M, Wei LJ, Sellers WR, et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004; 20:1233-1240.
16. Dumur CI, Dechsukhum C, Ware JL, et al. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 2003; 81:260-269.
17. Lips EH, Dierssen JW, van Eijk R, et al. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res 2005; 65:10188-10191.
18. Presneau N, Manderson EN, Tonin PN. The quest for a tumor suppressor gene phenotype. Curr Mol Med 2003; 3:605-629.
19. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000; 18:1001-1005.
20. Wang ZC, Buraimoh A, Iglehart JD, Richardson AL. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Breast Cancer Res Treat 2006; 97:301-309.
21. Janne PA, Li C, Zhao X, et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 2004; 23:2716-2726.
22. Irving JA, Bloodworth L, Bown NP, et al. Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. Cancer Res 2005; 65:3053-3058.
23. Sarquis MS, Weber F, Shen L, et al. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. J Clin Endocrinol Metab 2006; 91:262-269.
24. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6:17-32.
25. Beroukhim R, Lin M, Park Y, et al. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2006; 2:e41. Highly accurate method for determining LOH without paired normals.
26. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005; 65:375-378.
27. Langdon JA, Lamont JM, Scott DK, et al. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma. Genes Chromosomes Cancer 2006; 45:47-60.
28. Teh MT, Blaydon D, Chaplin T, et al. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005; 65:8597-8603.
29. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352:1779-1790.
30. Paez JG, Lin M, Beroukhim R, et al. Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 2004; 32:e71.
31. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98:31-36.
32. Huang J, Wei W, Zhang J, et al. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics 2004; 1:287-299.
33. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005; 65:6071-6079. Developed improved overall copy number detection and allele-specific copy number detection methods.
34. Ishikawa S, Komura D, Tsuji S, et al. Allelic dosage analysis with genotyping microarrays. Biochem Biophys Res Commun 2005; 333:1309-1314. Developed improved overall copy number detection and allele-specific copy number detection methods.
35. Huang J, Wei W, Chen J, et al. CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays. BMC Bioinformatics 2006; 7:83. Developed improved overall copy number detection and allele-specific copy number detection methods.
36. Rubin MA, Varambally S, Beroukhim R, et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res 2004; 64:3814-3822.
37. Koochekpour S, Zhuang YJ, Beroukhim R, et al. Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 2005; 44:351-364.
38. Tsafrir D, Bacolod M, Selvanayagam Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006; 66:2129-2137.
39. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436:117-122. Identified and functionally validated the oncogene MITF.
40. Park JT, Li M, Nakayama K, et al. Notch3 gene amplification in ovarian cancer. Cancer Res 2006; 66:6312-6318. Identified amplification of NOTCH 3, which appears to play a functional role in ovarian cancer.
41. LaFramboise T, Weir BA, Zhao X, et al. Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 2005; 1:e65. This paper develops a method to determine allele-specific copy-numbers from SNP array data and shows amplifications tend to be of a single allele.
42. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308:385-389.
43. Sellick GS, Webb EL, Allinson R, et al. A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. Am J Hum Genet 2005; 77:420-429.
44. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38:652-658.
45. Sellick GS, Longman C, Tolmie J, et al. Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res 2004; 32:e164.